Ignite Creation Date:
2025-12-24 @ 11:39 PM
Ignite Modification Date:
2025-12-28 @ 8:42 AM
Study NCT ID:
NCT05877651
Status:
COMPLETED
Last Update Posted:
2023-05-30
First Post:
2023-05-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
MASCT-I in Patients With Metastatic or Recurrent Solid Tumors Who Failed Standard Therapy.
Sponsor:
HRYZ Biotech Co.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MASCT-I-2001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None